Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 21, Issue 3, Pages -Publisher
MDPI
DOI: 10.3390/ijms21030952
Keywords
Alzheimer's disease; amyloid beta-protein (A beta); mAb158; oligomers; protofibrils
Funding
- Ministry of Education, Culture, Sports, Science and Technology, Japan [26461266]
- Japan Agency for Medical Research and Development [16dk0207021h0001]
Ask authors/readers for more resources
Worldwide, Alzheimer's disease (AD) is the most common age-related neurodegenerative disease and is characterized by unique pathological hallmarks in the brain, including plaques composed of amyloid beta-protein (A beta) and neurofibrillary tangles of tau protein. Genetic studies, biochemical data, and animal models have suggested that A beta is responsible for the pathogenesis of AD (i.e., the amyloid hypothesis). Indeed, A beta molecules tend to aggregate, forming oligomers, protofibrils, and mature fibrils. However, while these A beta species form amyloid plaques of the type implicated in AD neurodegeneration, recent clinical trials designed to reduce the production of A beta and/or the plaque burden have not demonstrated clinical efficacy. In addition, recent studies using synthetic Afi peptides, cell culture models, Arctic transgenic mice, and human samples of AD brain tissues have suggested that the pre-fibrillar forms of A beta, particularly A beta protofibrils, may be the most critical species, compared with extracellular fibrillar forms. We recently reported that protofibrils of A beta(1-42) disturbed membrane integrity by inducing reactive oxygen species generation and lipid peroxidation, resulting in decreased membrane fluidity, intracellular calcium dysregulation, depolarization, and synaptic toxicity. Therefore, the therapeutic reduction of protofibrils may prevent the progression of AD by ameliorating neuronal damage and cognitive dysfunction through multiple mechanisms.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available